Lilei Zhang

7PUBLICATIONS
43CO-AUTHORS
Gene and molecular therapyHealth and ecological risk assessmentEnergy generation, conversion and storage (excl. chemical and electrical)Cardiology (incl. cardiovascular diseases)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.

|Nov 14, 2023
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.

Weiyi Xu, Cyrielle Billon, Hui Li

|Mar 29, 2023
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.

Cyrielle Billon, Sadichha Sitaula, Subhashis Banerjee

|Feb 23, 2023
Lipid overload - a culprit for hypertrophic cardiomyopathy?

Lilei Zhang, Na Li

|Oct 14, 2022
Assigning pathogenicity for TAB2 variants using a novel scalable functional assay and expanding TAB2 disease spectrum.

Weiyi Xu, Andrea Graves, Monika Weisz-Hubshman

|Feb 21, 2022
LMOD2-related dilated cardiomyopathy presenting in late infancy.

Erica Lay, Mahshid S Azamian, Susan W Denfield

Pageof 2

Frequent Collaborators

2 joint publications

Weiyi Xu

2 joint publications

Brian C Jensen

1 joint publications

Erica Lay

1 joint publications

Weimin Bi